Patent details

Basic Information

Publication number:

EP3174869

PCT Application Number:

IB2015055737

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157475625

PCT Publication Number:

WO2016016822

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION THERAPY OF A MET INHIBITOR AND AN EGFR INHIBITOR

French Title of Invention:

POLYTHÉRAPIE AVEC UN INHIBITEUR DE MET ET UN INHIBITEUR D'EGFR

German Title of Invention:

KOMBINATIONSTHERAPIE VON EINEM MET-HEMMER UND EINEM EGFR-HEMMER

SPC Number:

Dates

Filing date:

29/07/2015

Grant date:

19/08/2020

EP Publication Date:

07/06/2017

PCT Publication Date:

04/02/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/08/2020

EP B1 Publication Date:

19/08/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/07/2021

Expiration date:

29/07/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/08/2020

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

HUANG, Xizhong

Address:

United States (US)

2

Name:

KASIBHATLA, Shailaja

Address:

United States (US)

3

Name:

HAO, Huaixiang

Address:

United States (US)

4

Name:

TAM, Angela

Address:

United States (US)

Priority

Priority Number:

201462031583 P

Priority Date:

31/07/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/53; A61K 31/55; A61P 35/00; C07D 401/14; C07D 487/04;

Publication

European Patent Bulletin

Issue number:

202034

Publication date:

19/08/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages